Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder marked primarily by β-amyloid (Aβ) deposition and abnormal ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

An Alzheimer’s diagnosis can be devastating and confusing. The recently released Alzheimer's Association app My ALZ Journey ...

As families across the U.S. prepare for fireworks and festivities this Independence Day, one organization is urging ...

Holstege was supported by ABOARD, a public-private partnership receiving funding from ZonMw and Health Holland, Topsector ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

Mayo Clinic's StateViewer AI tool improves dementia diagnosis, accurately identifying types from brain scans and doubling ...

Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer ...

According to a comprehensive market research report titled "Neurogenomics Market Size, Share, Forecast, & Trends Analysis by Offering ...

Upcoming FDA meeting During the second half of 2025, the Actinogen clinical, nonclinical, manufacturing and regulatory teams will meet with the US FDA to discuss the detailed potential pathways to FDA ...

Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process ...

We’ve medicalized long-term care so much that we’ve forgotten the people at its heart. But care can’t be complete without ...